Effects of smoking and obesity on the association between CDH13 (rs3865188) and adiponectin among Korean men: The KARE study

Obesity

Volumn 20, Issue 8, 2012, Pages 1683-1687

  Jo, Jaeseong ^a   Sull, Jae Woong ^a   Park , Eun Jung ^a   Jee, Sun Ha ^a  

^a Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADULT; AGED; ALLELE; ARTICLE; CDH13 GENE; COHORT ANALYSIS; COMMUNITY LIVING; ETHNIC GROUP; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; HYPOADIPONECTINEMIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEN'S HEALTH; OBESITY; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK ASSESSMENT; SMOKING; SOUTH KOREA; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CADHERINS; COHORT STUDIES; GENOTYPE; HUMANS; KOREA; MALE; METABOLISM, INBORN ERRORS; MIDDLE AGED; OBESITY; ODDS RATIO; RISK; SMOKING; WAIST CIRCUMFERENCE;

EID: 84864328506     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.128     Document Type: Article

References (41)

1. Matsuzawa Y. Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl 2005;6:7-14.
2. Maeda N, Takahashi M, Funahashi T et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001;50:2094-2099.
3. Yang WS, Tsou PL, Lee WJ et al. Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med 2003;81:428-434.
4. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935.
5. Kadowaki T, Yamauchi T, Kubota N. The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett 2008;582:74-80.
6. Zoccali C, Mallamaci F, Tripepi G et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002;13:134-141.
7. Ling H, Waterworth DM, Stirnadel HA et al. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring) 2009;17:737-744.
8. Andersson L, Petersen G, Ståhl F. Ranking candidate genes in rat models of type 2 diabetes. Theor Biol Med Model 2009;6:12.
9. Hug C, Wang J, Ahmad NS et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci USA 2004;101:10308-10313.
10. Rubina K, Kalinina N, Parfyonova Y et al. T-cadherin as a receptor regulating angiogenesis and blood vessel remodeling. Biochemistry 2007;1:62-69.
11. Sato M, Mori Y, Sakurada A, Fujimura S, Horii A. The H-cadherin (CDH13) gene is inactivated in human lung cancer. Hum Genet 1998;103:96-101.
12. Thomas G, Jacobs KB, Yeager M et al. Multiple loci identified in a genomewide association study of prostate cancer. Nat Genet 2008;40:310-315.
13. Hebbard LW, Garlatti M, Young LJ et al. T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. Cancer Res 2008;68:1407-1416.
14. Jee SH, Sull JW, Park J et al. Body-mass index and mortality in Korean men and women. N Engl J Med 2006;355:779-787.
15. Lawlor DA, Song YM, Sung J, Ebrahim S, Smith GD. The association of smoking and cardiovascular disease in a population with low cholesterol levels: a study of 648,346 men from the Korean national health system prospective cohort study. Stroke 2008;39:760-767.
16. Stewart ST, Cutler DM, Rosen AB. Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med 2009;361:2252-2260.
17. Sull JW, Kim HJ, Yun JE et al. Serum adiponectin is associated with smoking status in healthy Korean men. Endocr J 2009;56:73-78.
18. Madsen EL, Rissanen A, Bruun JM et al. Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. Eur J Endocrinol 2008;158:179-187.
19. Ntalla I, Dedoussis G, Yannakoulia M et al. ADIPOQ gene polymorphism rs1501299 interacts with fibre intake to affect adiponectin concentration in children: the GENe-Diet Attica Investigation on childhood obesity. Eur J Nutr 2009;48:493-497.
20. Cho YS, Go MJ, Kim YJ et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 2009;41:527-534.
21. Rabbee N, Speed TP. A genotype calling algorithm for affymetrix SNP arrays. Bioinformatics 2006;22:7-12.
22. Jin HS, Hong KW, Lim JE et al. Genetic variations in the sodium balanceregulating genes ENaC, NEDD4L, NDFIP2 and USP2 influence blood pressure and hypertension. Kidney Blood Press Res 2010;33:15-23.
23. Yoon SJ, Lee HS, Lee SW et al. The association between adiponectin and diabetes in the Korean population. Metabolism 2008;57: 853-857.
24. Yun JE, Sull JW, Lee HY et al. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients. Diabetes Metab Res Rev 2009;25:259-265.
25. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004;27:1182-1186.
26. Hosmer DW, Lemeshow S. Applied Logistic Regression. John Wiley & Sons, Inc, New York, NY, 2000.
27. Vendramini MF, Kasamatsu TS, Crispim F et al.; Japanese-Brazilian Diabetes Study Group. Novel mutation in the adiponectin (ADIPOQ) gene is associated with hypoadiponectinaemia in Japanese-Brazilians. Clin Endocrinol (Oxf) 2009;71:50-55.
28. Takeuchi T, Adachi Y, Ohtsuki Y et al. Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med Mol Morphol 2007;40:115-120.
29. Jee SH, Sull JW, Lee LE et al. Adiponectin concentrations: a genome-wide association study. Am J Hum Genet 2010;87:545-552.
30. Uhl GR, Liu QR, Drgon T et al. Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs. BMC Genet 2007;8:10.
31. Uhl GR, Liu QR, Drgon T et al. Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch Gen Psychiatry 2008;65:683-693.
32. Vuillemenot BR, Hutt JA, Belinsky SA. Gene promoter hypermethylation in mouse lung tumors. Mol Cancer Res 2006;4:267-273.
33. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004;5:153-165.
34. Mantzoros C, Petridou E, Dessypris N et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab 2004;89:1102-1107.
35. Körner A, Pazaitou-Panayiotou K, Kelesidis T et al. Total and high-molecularweight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 2007;92:1041-1048.
36. Chen X, Wang Y. Adiponectin and breast cancer. Med Oncol 2010; e-pub ahead of print 13 July 2010.
37. Ivanov D, Philippova M, Antropova J et al. Expression of cell adhesion molecule T-cadherin in the human vasculature. Histochem Cell Biol 2001;115:231-242.
38. Wong GW, Wang J, Hug C, Tsao TS, Lodish HF. A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci USA 2004;101:10302-10307.
39. Asada K, Yoshiji H, Noguchi R et al. Crosstalk between high-molecularweight adiponectin and T-cadherin during liver fibrosis development in rats. Int J Mol Med 2007;20:725-729.
40. Toyooka KO, Toyooka S, Virmani AK et al. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res 2001;61:4556-4560.
41. Pischon T, Hotamisligil GS, Rimm EB. Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem 2003;49: 650-652.